ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL granule, for suspension United States - English - NLM (National Library of Medicine)

erythromycin ethylsuccinate and sulfisoxazole acetyl granule, for suspension

physicians total care, inc. - erythromycin ethylsuccinate (unii: 1014ksj86f) (erythromycin - unii:63937kv33d), sulfisoxazole acetyl (unii: wbt5qh3ked) (sulfisoxazole - unii:740t4c525w) - erythromycin ethylsuccinate 200 mg in 5 ml - for treatment of acute otitis media in children that is caused by susceptible strains of haemophilus influenzae . erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension is contraindicated in the following patient populations: use in pregnant women at term, in children less than 2 months of age, and in mothers nursing infants less than 2 months of age is contraindicated because sulfonamides may promote kernicterus in the newborn by displacing bilirubin from plasma proteins. erythromycin is contraindicated in patients taking terfenadine. (see precautions, drug interactions:.)

ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL granule, for suspension United States - English - NLM (National Library of Medicine)

erythromycin ethylsuccinate and sulfisoxazole acetyl granule, for suspension

rebel distributors corp - erythromycin ethylsuccinate (unii: 1014ksj86f) (erythromycin - unii:63937kv33d), sulfisoxazole acetyl (unii: wbt5qh3ked) (sulfisoxazole - unii:740t4c525w) - erythromycin ethylsuccinate 200 mg in 5 ml - for treatment of acute otitis media in children that is caused by susceptible strains of haemophilus influenzae . erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension is contraindicated in the following patient populations: use in pregnant women at term, in children less than 2 months of age, and in mothers nursing infants less than 2 months of age is contraindicated because sulfonamides may promote kernicterus in the newborn by displacing bilirubin from plasma proteins. erythromycin is contraindicated in patients taking terfenadine. (see precautions, drug interactions:.)

TYLOSIN BIOVET JSC 200 MG/ML SOLUTION FOR INJECTION FOR CATTLE, SHEEP, GOATS AND PIGS Ireland - English - HPRA (Health Products Regulatory Authority)

tylosin biovet jsc 200 mg/ml solution for injection for cattle, sheep, goats and pigs

biovet joint stock company - tylosin - solution for injection - 200 mg/ml - tylosin - bovine, caprine, ovine, porcine - antibacterial

TYLOSIN BIOVET JSC 200 mg/ml solution for injection for cattle, sheep, goats and pigs Ireland - English - HPRA (Health Products Regulatory Authority)

tylosin biovet jsc 200 mg/ml solution for injection for cattle, sheep, goats and pigs

biovet joint stock company, - tylosin - solution for injection - 200,000 international unit(s)/millilitre - tylosin - cattle, goats, pigs, sheep - antibacterial

BIOVERA HAND SANITIZER WIPES- benzalkonium chloride liquid United States - English - NLM (National Library of Medicine)

biovera hand sanitizer wipes- benzalkonium chloride liquid

verataur, llc. - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - hand sanitizer wipes to help reduce bacteria on the skin antiseptic, hand sanitizer wipe

Biovetamox LA 15% 150mg/ mL Solution for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

biovetamox la 15% 150mg/ ml solution for injection (im/sc)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - amoxicillin (as trihydrate) - solution for injection (im/sc) - 150mg/ ml

ENJAYMO- sutimlimab-jome injection, solution, concentrate United States - English - NLM (National Library of Medicine)

enjaymo- sutimlimab-jome injection, solution, concentrate

bioverativ therapeutics inc. - sutimlimab (unii: gnwe7kj995) (sutimlimab - unii:gnwe7kj995) - cold agglutinin disease enjaymo (sutimlimab-jome) is indicated for the treatment of hemolysis in adults with cold agglutinin disease (cad). enjaymo is contraindicated in patients with known hypersensitivity to sutimlimab-jome or any of the inactive ingredients [see warnings and precautions (5.2) and adverse reactions (6.1)] . risk summary there are no available data on enjaymo use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. human immunoglobulin g (igg) antibodies are known to cross the placental barrier; therefore, sutimlimab-jome may be transmitted from the mother to the developing fetus. in animal reproduction studies, intravenous administration of sutimlimab-jome to pregnant monkeys during organogenesis at doses 2 to 3 times the maximum recommended human doses did not result in adverse effects on pregnancy or offspring development (see

Biovest Egypt - English - EDA (Egyptian Drug Authority)

biovest

kirovest pharmaceutical co. , egypt - toltrazuril 25gm /1liter - oral solution

Biovent 200 mcg/ 1 mg per mL Solution For Inhalation Philippines - English - FDA (Food And Drug Administration)

biovent 200 mcg/ 1 mg per ml solution for inhalation

sahar international trading, inc.; distributor: marzan pharma corporation - ipratropium bromide , salbutamol (as sulfate) - solution for inhalation - 200 mcg/ 1 mg per ml